AI assistant
Medtronic plc — Director's Dealing 2016
Apr 5, 2016
29841_dirs_2016-04-05_1ec32d6b-e17f-439d-8483-1ae0803de9a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-04-01
Reporting Person: Kuntz Richard (SrVP & Chief Scien, Clin, Reg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-01 | Ordinary Shares | S | 4000 | $75.2197 | Disposed | 104358 | Direct |
Footnotes
F1: This balance increased by 269 shares due to exempt transactions such as dividend reinvestment.
F2: The price reported in Column 4 is a weighted Average price. The shares were sold in multiple transactions at prices ranging from $75.2701 to $75.47, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.